Concepts (240)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Health Care Costs | 5 | 2024 | 207 | 1.300 |
Why?
|
| Depression | 8 | 2023 | 486 | 1.230 |
Why?
|
| Chronic Pain | 5 | 2024 | 127 | 1.230 |
Why?
|
| Depressive Disorder | 7 | 2018 | 185 | 1.090 |
Why?
|
| Gastroenteritis | 2 | 2024 | 26 | 1.050 |
Why?
|
| Cost-Benefit Analysis | 10 | 2023 | 226 | 1.010 |
Why?
|
| Delivery of Health Care, Integrated | 6 | 2024 | 535 | 0.950 |
Why?
|
| Cost of Illness | 2 | 2024 | 92 | 0.940 |
Why?
|
| Humans | 57 | 2025 | 17314 | 0.810 |
Why?
|
| Adolescent | 29 | 2024 | 3538 | 0.790 |
Why?
|
| Behavior Therapy | 7 | 2023 | 126 | 0.730 |
Why?
|
| Hallucinogens | 1 | 2022 | 23 | 0.720 |
Why?
|
| Male | 36 | 2025 | 9804 | 0.670 |
Why?
|
| Female | 41 | 2025 | 12396 | 0.660 |
Why?
|
| Quality of Life | 6 | 2023 | 499 | 0.660 |
Why?
|
| Cannabis | 1 | 2022 | 85 | 0.650 |
Why?
|
| Myocardial Infarction | 1 | 2022 | 224 | 0.650 |
Why?
|
| Stroke | 1 | 2022 | 309 | 0.610 |
Why?
|
| Depressive Disorder, Major | 5 | 2022 | 100 | 0.540 |
Why?
|
| Anxiety Disorders | 6 | 2023 | 92 | 0.540 |
Why?
|
| Child | 14 | 2024 | 2403 | 0.520 |
Why?
|
| Neoplasms | 4 | 2022 | 446 | 0.480 |
Why?
|
| Middle Aged | 18 | 2025 | 7836 | 0.460 |
Why?
|
| Analgesics, Opioid | 4 | 2022 | 245 | 0.460 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2022 | 381 | 0.460 |
Why?
|
| Binge-Eating Disorder | 2 | 2010 | 13 | 0.430 |
Why?
|
| Serotonin Uptake Inhibitors | 4 | 2020 | 46 | 0.430 |
Why?
|
| Delivery of Health Care | 2 | 2018 | 390 | 0.380 |
Why?
|
| Electronic Health Records | 6 | 2021 | 704 | 0.380 |
Why?
|
| Adult | 18 | 2024 | 7500 | 0.380 |
Why?
|
| United States | 11 | 2025 | 3866 | 0.350 |
Why?
|
| Young Adult | 11 | 2024 | 2465 | 0.350 |
Why?
|
| Treatment Outcome | 12 | 2022 | 1160 | 0.350 |
Why?
|
| Aged | 10 | 2025 | 6084 | 0.350 |
Why?
|
| Telemedicine | 2 | 2024 | 181 | 0.340 |
Why?
|
| Acupuncture Therapy | 3 | 2017 | 32 | 0.340 |
Why?
|
| Musculoskeletal Pain | 3 | 2017 | 24 | 0.340 |
Why?
|
| Chronic Disease | 3 | 2022 | 397 | 0.310 |
Why?
|
| Dental Facilities | 1 | 2009 | 1 | 0.310 |
Why?
|
| Referral and Consultation | 2 | 2017 | 157 | 0.300 |
Why?
|
| Primary Health Care | 7 | 2022 | 726 | 0.300 |
Why?
|
| Tobacco Use Cessation | 1 | 2009 | 18 | 0.300 |
Why?
|
| Health Plan Implementation | 1 | 2009 | 35 | 0.290 |
Why?
|
| Genetic Carrier Screening | 2 | 2018 | 16 | 0.290 |
Why?
|
| Combined Modality Therapy | 7 | 2014 | 114 | 0.290 |
Why?
|
| Anxiety | 4 | 2023 | 154 | 0.290 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 2 | 2022 | 6 | 0.280 |
Why?
|
| Hotlines | 1 | 2007 | 10 | 0.280 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 1282 | 0.280 |
Why?
|
| Follow-Up Studies | 8 | 2019 | 1151 | 0.280 |
Why?
|
| Nicotine | 1 | 2007 | 27 | 0.270 |
Why?
|
| Tobacco Use Disorder | 1 | 2007 | 36 | 0.270 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2020 | 34 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2025 | 664 | 0.270 |
Why?
|
| Smoking Cessation | 1 | 2007 | 154 | 0.250 |
Why?
|
| Medicare | 2 | 2025 | 192 | 0.250 |
Why?
|
| Antidepressive Agents | 3 | 2018 | 142 | 0.240 |
Why?
|
| Exercise | 4 | 2021 | 515 | 0.240 |
Why?
|
| Child, Preschool | 3 | 2024 | 1380 | 0.240 |
Why?
|
| Social Security | 1 | 2005 | 1 | 0.230 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 173 | 0.230 |
Why?
|
| Health Services Research | 3 | 2018 | 202 | 0.230 |
Why?
|
| Community Health Centers | 1 | 2025 | 64 | 0.230 |
Why?
|
| Needs Assessment | 1 | 2025 | 65 | 0.230 |
Why?
|
| Taxes | 1 | 2005 | 23 | 0.230 |
Why?
|
| Rural Population | 1 | 2024 | 55 | 0.220 |
Why?
|
| History, 21st Century | 1 | 2024 | 25 | 0.220 |
Why?
|
| Health Care Reform | 1 | 2003 | 20 | 0.210 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2003 | 23 | 0.210 |
Why?
|
| Manipulation, Chiropractic | 2 | 2015 | 18 | 0.210 |
Why?
|
| Acute Disease | 1 | 2024 | 144 | 0.210 |
Why?
|
| Infant | 2 | 2024 | 1161 | 0.210 |
Why?
|
| Cohort Studies | 4 | 2022 | 2514 | 0.200 |
Why?
|
| Rotavirus | 1 | 2022 | 20 | 0.200 |
Why?
|
| Rotavirus Infections | 1 | 2022 | 33 | 0.200 |
Why?
|
| Rotavirus Vaccines | 1 | 2022 | 53 | 0.190 |
Why?
|
| Vomiting | 1 | 2022 | 15 | 0.190 |
Why?
|
| Patient Acuity | 1 | 2022 | 7 | 0.190 |
Why?
|
| Hawaii | 1 | 2022 | 58 | 0.190 |
Why?
|
| Suicide, Attempted | 1 | 2022 | 92 | 0.180 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2012 | 19 | 0.180 |
Why?
|
| Pharmacy | 1 | 2021 | 12 | 0.180 |
Why?
|
| Accelerometry | 1 | 2021 | 51 | 0.170 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2017 | 104 | 0.170 |
Why?
|
| Cancer Survivors | 2 | 2019 | 101 | 0.170 |
Why?
|
| Autism Spectrum Disorder | 1 | 2023 | 159 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2025 | 529 | 0.160 |
Why?
|
| Quality-Adjusted Life Years | 2 | 2018 | 37 | 0.160 |
Why?
|
| Self Care | 2 | 2011 | 144 | 0.160 |
Why?
|
| Patient Compliance | 2 | 2019 | 277 | 0.160 |
Why?
|
| Survivorship | 1 | 2019 | 12 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2025 | 622 | 0.160 |
Why?
|
| Pragmatic Clinical Trials as Topic | 2 | 2024 | 61 | 0.150 |
Why?
|
| Railroads | 1 | 2019 | 3 | 0.150 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 9 | 0.150 |
Why?
|
| Neonatal Screening | 1 | 2018 | 12 | 0.140 |
Why?
|
| Health Surveys | 1 | 2019 | 245 | 0.140 |
Why?
|
| Environment Design | 1 | 2019 | 67 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 33 | 0.140 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 19 | 0.140 |
Why?
|
| Genomics | 1 | 2018 | 56 | 0.140 |
Why?
|
| Life Style | 2 | 2012 | 316 | 0.140 |
Why?
|
| Cyclohexanols | 3 | 2012 | 19 | 0.140 |
Why?
|
| Longitudinal Studies | 2 | 2017 | 674 | 0.140 |
Why?
|
| Health Behavior | 3 | 2012 | 346 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2018 | 72 | 0.140 |
Why?
|
| Program Evaluation | 2 | 2009 | 205 | 0.140 |
Why?
|
| Psychotherapy, Brief | 1 | 2017 | 19 | 0.130 |
Why?
|
| Internet | 2 | 2009 | 212 | 0.130 |
Why?
|
| Parents | 2 | 2020 | 297 | 0.130 |
Why?
|
| Psychology, Adolescent | 1 | 2016 | 10 | 0.130 |
Why?
|
| Propensity Score | 1 | 2017 | 76 | 0.130 |
Why?
|
| Drug Costs | 1 | 2016 | 32 | 0.120 |
Why?
|
| Cardiovascular Agents | 1 | 2016 | 22 | 0.120 |
Why?
|
| Child of Impaired Parents | 1 | 2015 | 27 | 0.120 |
Why?
|
| Weight Loss | 2 | 2022 | 294 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2016 | 74 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2023 | 1226 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2022 | 2415 | 0.110 |
Why?
|
| Patient Education as Topic | 1 | 2016 | 193 | 0.110 |
Why?
|
| Commerce | 1 | 2014 | 36 | 0.110 |
Why?
|
| Buprenorphine | 1 | 2014 | 48 | 0.110 |
Why?
|
| Oregon | 2 | 2019 | 170 | 0.100 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2013 | 26 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2016 | 235 | 0.100 |
Why?
|
| Phenotype | 1 | 2013 | 149 | 0.100 |
Why?
|
| Adolescent Behavior | 2 | 2012 | 121 | 0.100 |
Why?
|
| Health Maintenance Organizations | 3 | 2015 | 407 | 0.100 |
Why?
|
| Anhedonia | 1 | 2012 | 4 | 0.090 |
Why?
|
| Counseling | 2 | 2014 | 174 | 0.090 |
Why?
|
| Bulimia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Pharmacists | 2 | 2021 | 48 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 532 | 0.090 |
Why?
|
| Manuals as Topic | 1 | 2010 | 5 | 0.080 |
Why?
|
| Suicide | 1 | 2012 | 116 | 0.080 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2023 | 312 | 0.080 |
Why?
|
| Bone Density | 2 | 2008 | 94 | 0.080 |
Why?
|
| Overweight | 1 | 2012 | 266 | 0.080 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2012 | 302 | 0.080 |
Why?
|
| Diet | 2 | 2012 | 355 | 0.080 |
Why?
|
| Self-Help Groups | 1 | 2009 | 27 | 0.070 |
Why?
|
| Translational Medical Research | 1 | 2009 | 33 | 0.070 |
Why?
|
| Hospitalization | 2 | 2025 | 804 | 0.070 |
Why?
|
| Advertising as Topic | 1 | 2007 | 9 | 0.070 |
Why?
|
| Telephone | 1 | 2009 | 150 | 0.070 |
Why?
|
| Feeding Behavior | 1 | 2008 | 163 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 2007 | 16 | 0.070 |
Why?
|
| Patient Satisfaction | 1 | 2009 | 191 | 0.070 |
Why?
|
| Smoking Prevention | 1 | 2007 | 35 | 0.070 |
Why?
|
| Venlafaxine Hydrochloride | 3 | 2012 | 20 | 0.070 |
Why?
|
| Risk Factors | 2 | 2022 | 3258 | 0.070 |
Why?
|
| Health Services | 1 | 2007 | 110 | 0.060 |
Why?
|
| Northwestern United States | 2 | 2021 | 53 | 0.060 |
Why?
|
| Time Factors | 3 | 2016 | 1039 | 0.060 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1925 | 0.060 |
Why?
|
| Patient Navigation | 1 | 2025 | 18 | 0.060 |
Why?
|
| California | 2 | 2025 | 2311 | 0.060 |
Why?
|
| Social Isolation | 1 | 2025 | 16 | 0.060 |
Why?
|
| Investments | 1 | 2005 | 1 | 0.060 |
Why?
|
| Text Messaging | 1 | 2025 | 34 | 0.060 |
Why?
|
| Health Promotion | 1 | 2007 | 279 | 0.060 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.060 |
Why?
|
| Pain Management | 1 | 2024 | 53 | 0.060 |
Why?
|
| Psychometrics | 2 | 2017 | 119 | 0.060 |
Why?
|
| Budgets | 1 | 2003 | 5 | 0.050 |
Why?
|
| Insurance Benefits | 1 | 2003 | 13 | 0.050 |
Why?
|
| Deductibles and Coinsurance | 1 | 2003 | 31 | 0.050 |
Why?
|
| Veterans | 1 | 2024 | 145 | 0.050 |
Why?
|
| Age Factors | 1 | 2005 | 878 | 0.050 |
Why?
|
| Child Health | 1 | 2023 | 39 | 0.050 |
Why?
|
| Drug Prescriptions | 1 | 2003 | 146 | 0.050 |
Why?
|
| Minority Groups | 1 | 2023 | 104 | 0.050 |
Why?
|
| Patient Health Questionnaire | 1 | 2022 | 18 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 384 | 0.050 |
Why?
|
| Drug Resistance | 2 | 2012 | 19 | 0.050 |
Why?
|
| Glycated Hemoglobin A | 1 | 2022 | 184 | 0.050 |
Why?
|
| Vital Signs | 1 | 2021 | 12 | 0.040 |
Why?
|
| Biomarkers | 2 | 2016 | 307 | 0.040 |
Why?
|
| Sleep Hygiene | 1 | 2020 | 2 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 6 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 367 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 126 | 0.040 |
Why?
|
| Patient Participation | 1 | 2021 | 119 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2011 | 81 | 0.040 |
Why?
|
| Communication | 1 | 2021 | 178 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 26 | 0.040 |
Why?
|
| Motivation | 1 | 2019 | 115 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2018 | 2 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2018 | 10 | 0.040 |
Why?
|
| Income | 1 | 2018 | 86 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 336 | 0.040 |
Why?
|
| Preconception Care | 1 | 2018 | 40 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2018 | 306 | 0.030 |
Why?
|
| Interview, Psychological | 1 | 2016 | 15 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2019 | 253 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 2016 | 12 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2016 | 30 | 0.030 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2016 | 8 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1098 | 0.030 |
Why?
|
| Models, Economic | 1 | 2016 | 17 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2012 | 937 | 0.030 |
Why?
|
| Health Resources | 1 | 2016 | 34 | 0.030 |
Why?
|
| Medical Record Linkage | 1 | 2016 | 36 | 0.030 |
Why?
|
| Insurance, Health | 1 | 2017 | 170 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2018 | 805 | 0.030 |
Why?
|
| Actigraphy | 1 | 2015 | 14 | 0.030 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2016 | 84 | 0.030 |
Why?
|
| Utilization Review | 1 | 2014 | 42 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 211 | 0.030 |
Why?
|
| Cognition | 1 | 2015 | 81 | 0.030 |
Why?
|
| Risk | 1 | 2015 | 496 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 165 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2018 | 1076 | 0.030 |
Why?
|
| Pregnancy | 1 | 2018 | 1463 | 0.020 |
Why?
|
| Personality Assessment | 1 | 2012 | 11 | 0.020 |
Why?
|
| Drug Substitution | 1 | 2012 | 7 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 21 | 0.020 |
Why?
|
| United States Food and Drug Administration | 1 | 2012 | 32 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 142 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 55 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 1280 | 0.020 |
Why?
|
| Psychotherapy | 1 | 2012 | 56 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 107 | 0.020 |
Why?
|
| Program Development | 1 | 2011 | 63 | 0.020 |
Why?
|
| Patient Selection | 1 | 2012 | 176 | 0.020 |
Why?
|
| Anorexia Nervosa | 1 | 2010 | 5 | 0.020 |
Why?
|
| Bulimia Nervosa | 1 | 2010 | 10 | 0.020 |
Why?
|
| Cost Savings | 1 | 2010 | 20 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2010 | 48 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2011 | 96 | 0.020 |
Why?
|
| Outcome Assessment (Health Care) | 1 | 2011 | 215 | 0.020 |
Why?
|
| Retention (Psychology) | 1 | 2008 | 6 | 0.020 |
Why?
|
| Calcium | 1 | 2008 | 30 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2010 | 300 | 0.020 |
Why?
|
| Office Visits | 1 | 2007 | 73 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 68 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2006 | 4 | 0.020 |
Why?
|
| Naltrexone | 1 | 2006 | 15 | 0.020 |
Why?
|
| Diet Surveys | 1 | 2006 | 56 | 0.020 |
Why?
|
| Comorbidity | 1 | 2007 | 560 | 0.020 |
Why?
|
Concepts
(240)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(26)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->